A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants

Clinical trial NCT07652723 · RECRUITING

Trial details

NCT number: NCT07652723
Sponsor: Bayer
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Drug-drug Interaction

Start date: 2026-05-29
Primary completion: 2026-10-15
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.